Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Ventripoint Diagnostics Ltd
(OP:
VPTDF
)
0.1369
-0.0064 (-4.47%)
Streaming Delayed Price
Updated: 1:17 PM EDT, Aug 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
3,260
Open
0.1379
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
0.1433
Today's Range
0.1308 - 0.1379
52wk Range
0.0982 - 0.2687
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Ventripoint Welcomes Evelina London Children's Hospital as Newest VMS+ User
August 22, 2023
Toronto, Ontario – TheNewswire – August 22, 2023 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT) (OTC:VPTDF) is pleased to announce that Evelina London Children’s Hospital...
Via
TheNewswire.com
Ventripoint to Exhibit at the American College of Cardiology 71st Annual Scientific Session and Expo and Correction to North Equities Corp Grant of Stock Options
April 01, 2022
Toronto, Ontario – TheNewswire – April 1, 2022 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT); (OTC:VPTDF) is pleased to announce that it will be exhibiting at the 71st...
Via
TheNewswire.com
Performance
YTD
-42.84%
-42.84%
1 Month
-5.59%
-5.59%
3 Month
-16.37%
-16.37%
6 Month
-36.74%
-36.74%
1 Year
-32.89%
-32.89%
More News
Read More
Ventripoint Announces Patent Application for Improved Heart Analysis
August 09, 2021
Via
TheNewswire.com
Topics
Artificial Intelligence
Intellectual Property
Exposures
Artificial Intelligence
Intellectual Property
Ventripoint Engages Digital257 for Social Media and Investor Relations Services
July 05, 2021
Via
TheNewswire.com
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Ventripoint Issues Option Grants to Consultants and a Director of the Corporation
July 02, 2021
Via
TheNewswire.com
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Ventripoint Announces Sponsorship for the 54th Annual Meeting of the Association of European Paediatric and Congenital Cardiology
May 21, 2021
Via
TheNewswire.com
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Ventripoint update on its Financial Status and on Warrant and Option Exercises
May 06, 2021
Via
TheNewswire.com
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
COVID-19
Ventripoint Receives Government Funding to Advance Development of Next Generation of VMS+
May 04, 2021
Via
TheNewswire.com
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
COVID-19
Ventripoint Collaborates with GE Healthcare to Bring More Functionality to its Cardiac Ultrasound Devices
April 27, 2021
Via
TheNewswire.com
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Ventripoint Attends 23rd Annual Canadian Echo Weekend and Grants Stock Options
April 20, 2021
Via
TheNewswire.com
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Ventripoint Extends Patent Portfolio with Foundational U.S. Provisional Patent Filing of Heart Motion Tracking Technology
April 19, 2021
Via
TheNewswire.com
Topics
Artificial Intelligence
Intellectual Property
Exposures
Artificial Intelligence
COVID-19
Intellectual Property
Ventripoint Announces Sponsorship for the 2021 Canadian Society of Echocardiography Weekend Conference
April 15, 2021
Via
TheNewswire.com
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Ventripoint Diagnostics Begins Publication of Case Studies Showing Meritorious Use of the VMS Heart Analysis System
April 13, 2021
Via
TheNewswire.com
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
COVID-19
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.